Significance of suboptimal response to imatinib, as defined by the European LeukemiaNet, in the long-term outcome of patients with early chronic myeloid leukemia in chronic phase

Yesid Alvarado, Hagop Kantarjian, Susan O'Brien, Stefan Faderl, Gautam Borthakur, Jan Burger, William Wierda, Guillermo Garcia-Manero, Jianqin Shan, Jorge Cortes

Research output: Contribution to journalArticlepeer-review

85 Scopus citations

Fingerprint Dive into the research topics of 'Significance of suboptimal response to imatinib, as defined by the European LeukemiaNet, in the long-term outcome of patients with early chronic myeloid leukemia in chronic phase'. Together they form a unique fingerprint.

Medicine & Life Sciences